Suchergebnisse - "Stagno, Fabio"

PubPharm (33)

1

Managing chronic myeloid leukemia for treatment-free remission : a proposal from the GIMEMA CML WP

enthalten in: Blood advances | 2019

von Baccarani, M. | Abruzzese, E. | Accurso, V. | +58

2

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia : a position paper

enthalten in: Journal of hematology & oncology | 2019

von Soverini, S. | Abruzzese, E. | Bocchia, M. | +13

3

Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib

enthalten in: In vivo (Athens, Greece) | 2019

von Stella, S. | Tirró, E. | Massimino, M. | +11

4

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

enthalten in: Haematologica | 2019

von Fava, C. | Rege-Cambrin, G. | Dogliotti, I. | +42

5

Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention

enthalten in: International journal of cardiology | 2019

von Caocci, G. | Mulas, O. | Bonifacio, M. | +23

6

Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)

enthalten in: Anticancer research | 2019

von Tirrò, E. | Massimino, M. | Stella, S. | +12

7

Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript : A Case Report

enthalten in: Anticancer research | 2019

von Massimino, M. | Stella, S. | Tirrò, E. | +9

8

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation

enthalten in: Cancer medicine | 2019

von Bernardi, S. | Malagola, M. | Zanaglio, C. | +21

9

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib

enthalten in: International journal of molecular sciences | 2019

von Stella, S. | Zammit, V. | Vitale, S. | +21

10

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice : Identification of risk factors and the role of prophylaxis

enthalten in: American journal of hematology | 2018

von Caocci, G. | Mulas, O. | Annunziata, M. | +33